Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab and Radiation for CUP
NCT03396471Phase 2Terminated
- Sponsor
- Hoosier Cancer Research Network
- Start
- Feb 2018
- Primary completion
- Aug 2021
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in carcinoma of unknown primary (CUP), sponsored by Hoosier Cancer Research Network. Started Feb 2018; status: terminated.
02
Drugs
03
Conditions
carcinoma of unknown primary (CUP)
Beyond the preview
Go deeper on NCT03396471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03396471.